“Effectiveness and Safety Profile of Tofacitinib and Baricitinib in Rheumatoid Arthritis Patients: Results from a 24-Month Real-Life Prospective Study in Southern-Italy”. Reumatismo, vol. 74, no. 3, Dec. 2022, https://doi.org/10.4081/reumatismo.2022.1511.